Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Superficial vein thrombosis? 32 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Superficial vein thrombosis have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.

32
Reports of Superficial vein thrombosis with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
4
Deaths
6
Hospitalizations

How Dangerous Is Superficial vein thrombosis From LENALIDOMIDE?

Of the 32 reports, 4 (12.5%) resulted in death, 6 (18.8%) required hospitalization, and 1 (3.1%) were considered life-threatening.

Is Superficial vein thrombosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 32 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Superficial vein thrombosis?

PREDNISONE (44) UPADACITINIB (38) CARBOPLATIN (37) RITUXIMAB (32) HUMAN IMMUNOGLOBULIN G (29) IRON SUCROSE (22) METHOTREXATE (22) CANDESARTAN CILEXETIL (20) CLOPIDOGREL BISULFATE (20) ESOMEPRAZOLE (20)

Which LENALIDOMIDE Alternatives Have Lower Superficial vein thrombosis Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Superficial vein thrombosis Reports All Drugs Causing Superficial vein thrombosis LENALIDOMIDE Demographics